| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/20/1995 | WO1995019180A1 Anti-gram-positive bacterial methods and materials |
| 07/20/1995 | WO1995019179A1 Anti-fungal methods and materials |
| 07/20/1995 | WO1995019178A1 Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders |
| 07/20/1995 | WO1995019167A1 Therapeutic treatment for inhibiting vascular restenosis |
| 07/20/1995 | WO1995007995A3 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/20/1995 | DE4432262A1 Combination prepn. for treatment of digestive tract disorders |
| 07/20/1995 | CA2181171A1 T cell antigen receptor v region proteins and methods of preparation thereof |
| 07/20/1995 | CA2181170A1 Somatic gene therapy to cells associated with fluid spaces |
| 07/20/1995 | CA2181142A1 Cross-reactive allergen |
| 07/20/1995 | CA2181035A1 Therapeutic treatment for inhibiting vascular restenosis |
| 07/20/1995 | CA2180748A1 Ion-channel forming amphiphilic peptides having n-terminal modifications |
| 07/20/1995 | CA2180740A1 Method and reagent for inhibiting hepatitis c virus replication |
| 07/20/1995 | CA2180347A1 Anti-hepatitis b poly- and oligonucleotides |
| 07/20/1995 | CA2179990A1 Biological targeting agents |
| 07/20/1995 | CA2179391A1 Cd44 expression in smooth muscle cells |
| 07/20/1995 | CA2179280A1 Peptides and methods against psoriasis |
| 07/19/1995 | EP0663407A1 Process for preparation of reconstituted lipoproteins |
| 07/19/1995 | EP0663406A1 VIP analog |
| 07/19/1995 | EP0663211A1 Agent for preventing and treating digestive mucosal disorders |
| 07/19/1995 | EP0663014A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 07/19/1995 | EP0663009A1 High molecular weight desulphatohirudin |
| 07/19/1995 | EP0663007A1 Trophic factor having ion channel-inducing activity in neuronal cells |
| 07/19/1995 | EP0663006A1 Human calcitonin receptor |
| 07/19/1995 | EP0662976A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/19/1995 | EP0662841A1 Pharmaceutical composition for site-specific release of a clot-dissolving protein |
| 07/19/1995 | EP0662839A1 Vaccines and antigenic conjugates |
| 07/19/1995 | EP0662838A1 Method of treating rheumatoid arthritis with type ii collagen |
| 07/19/1995 | EP0662837A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
| 07/19/1995 | EP0662836A1 Germicidal detergent-iodine compositions having reduced detergent content |
| 07/19/1995 | EP0662827A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/19/1995 | EP0662782A1 Pp14-based therapy |
| 07/19/1995 | EP0646129A4 Receptor-type tyrosine kinase-like molecules. |
| 07/19/1995 | EP0424416B1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex |
| 07/19/1995 | EP0386240B1 Novel polypeptide compounds |
| 07/18/1995 | US5434287 Bifunctional DTPA-type ligand |
| 07/18/1995 | US5434261 Benzo-fused lactams promote release of growth hormone |
| 07/18/1995 | US5434250 Process for manufacturing high α-lactalbumin content composition |
| 07/18/1995 | US5434248 Peptidyl derivatives as inhibitors of interleukin-1β converting enzyme |
| 07/18/1995 | US5434247 Lymphokines; oligopeptides; cancer therapy |
| 07/18/1995 | US5434246 Polypeptide, bone disorders |
| 07/18/1995 | US5434245 Osteocalcin |
| 07/18/1995 | US5434139 Male fertility |
| 07/18/1995 | US5434138 Gonadoliberin antagonists |
| 07/18/1995 | US5434137 Method for selective opening of abnormal brain tissue capillaries |
| 07/18/1995 | US5434136 Administering an analog of gonadotropin releasing hormone to a patient suffering from systemic lupus erythematosis |
| 07/18/1995 | US5434135 Growth factor compositions, preparation and use |
| 07/18/1995 | US5434134 Use of human IGF-1 to treat cardiac disorders |
| 07/18/1995 | US5434133 CNP analog peptides and their use |
| 07/18/1995 | US5434132 Neuropeptide antagonists |
| 07/18/1995 | US5434131 Chimeric CTLA4 receptor and methods for its use |
| 07/18/1995 | US5434086 Method of testing potential cystic fibrosis treating compounds using cells in culture |
| 07/18/1995 | US5434077 Borrelia burgdorferi strain 257 |
| 07/18/1995 | US5434075 Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses |
| 07/18/1995 | US5434074 Cytomegalovirus proteinase |
| 07/18/1995 | US5434073 Fibrinolytic and anti-thrombotic cleavable dimers |
| 07/18/1995 | US5434064 Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins |
| 07/18/1995 | US5434059 Thrombolytic agent and process of preparation thereof |
| 07/18/1995 | US5434058 Apolipoprotein B MRNA editing protein compositions and methods |
| 07/18/1995 | US5434046 Ovarian cancer |
| 07/18/1995 | US5433951 Sustained release formulation containing captopril and method |
| 07/18/1995 | US5433948 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 07/18/1995 | US5433946 Synthesis and utilization of therapeutic agents for the treatment of lysosomal storage diseases |
| 07/18/1995 | US5433944 Therapeutic agent for corneal disorders |
| 07/18/1995 | US5433942 Composition and method of treating depigmentation disorders |
| 07/18/1995 | US5433940 Synthetic molecules mimic action of hirudin by binding to both the low affinity anion-binding exosite and the catalytic site of thrombin |
| 07/18/1995 | CA1336349C Nitrogenous polycyclic tripeptides, their preparation and pharmaceutical compositions containing them |
| 07/18/1995 | CA1336348C Process for industrial synthesis of perindopril and its major synthesis intermediates |
| 07/18/1995 | CA1336322C Use of hemocyanins and arylphorins to influence the immune system and for the treatment of tumors |
| 07/18/1995 | CA1336321C Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
| 07/15/1995 | CA2113494A1 Method for assaying for substances which affect bcr-abl mediated transformation |
| 07/13/1995 | WO1995018863A1 Composition containing nucleic acids, preparation and uses |
| 07/13/1995 | WO1995018860A1 Control of marek's disease by the inhibition of latency and tumor cell development |
| 07/13/1995 | WO1995018859A1 Synergistic antifungal protein and compositions containing same |
| 07/13/1995 | WO1995018858A1 Thrombopoietin |
| 07/13/1995 | WO1995018857A1 Association of kinesin with sensitivity to chemotherapeutic drugs |
| 07/13/1995 | WO1995018856A1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 07/13/1995 | WO1995018855A2 Synthetic antimicrobial peptides |
| 07/13/1995 | WO1995018854A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/13/1995 | WO1995018830A2 Inhibitors of human plasmin derived from the kunitz domains |
| 07/13/1995 | WO1995018829A1 Factor viii derivatives |
| 07/13/1995 | WO1995018828A1 Factor viii derivatives |
| 07/13/1995 | WO1995018827A1 Factor viii derivatives |
| 07/13/1995 | WO1995018826A2 Purified primate ctla-8 antigens and related reagents |
| 07/13/1995 | WO1995018825A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis |
| 07/13/1995 | WO1995018824A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/13/1995 | WO1995018819A1 Ligand that binds fas antigen |
| 07/13/1995 | WO1995018635A1 Low molecular weight hyaluronic acid with peptide or protein |
| 07/13/1995 | WO1995018634A1 Human monoclonal antibodies to herpes simplex virus and methods therefor |
| 07/13/1995 | WO1995018632A1 Nucleotide and amino acid sequences of a t. pallidum rare outer membrane protein |
| 07/13/1995 | WO1995018630A1 A method to produce a substance to inhibit cell penetration, and a contraceptive to prevent conception, and a thrombus, prostate and aids vaccine and medicine |
| 07/13/1995 | WO1995018629A1 Method for treatment and prevention of disease in animals |
| 07/13/1995 | WO1995018628A1 Method for embryo abortion |
| 07/13/1995 | WO1995018627A1 Method of making polymers having specific properties |
| 07/13/1995 | WO1995018626A1 A tonic drug made from basidiomycetes, algae, chinese herbal medicine and the method thereof |
| 07/13/1995 | WO1995018618A2 Enteral formula with ribo-nucleotides |
| 07/13/1995 | WO1995018614A1 Method for treatment of obesity using prolactin modulators and diet |
| 07/13/1995 | WO1995018609A1 Human leukocyte 12-lipoxygenase, mediation of its pathway, and consequences thereof |
| 07/13/1995 | WO1995018547A1 Method of enhancing the human immune system |
| 07/13/1995 | WO1995016035A3 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
| 07/13/1995 | WO1995013095A3 Therapy |